Cipla Limited (Cipla) announced that it has agreed to further invest INR 42 crore (approx.) in digital tech company GoApptiv Private Limited (GoApptiv). In line with Cipla’s ambition to strengthen investments in channels of the future, this development will further expand Cipla’s presence across the healthcare continuum, especially to the underserved population by enabling greater…
Pharma major Cipla announced it has sold its entire stake of 51% in Saba Investment Limited (Saba) to Shibam Group Holding Limited. According to the company’s exchange filing, “, we hereby notify that the Company has entered into a binding term sheet to sell its entire stake of 51% held in Saba Investment Limited, UAE…
Cipla Limited referred to as Cipla announced that its wholly-owned UK subsidiary, Cipla (EU) Limited (Cipla EU) has signed definitive agreements for equity investment of EUR 15 million in Ethris GmbH (Ethris), a global leader in delivering mRNAs directly to the respiratory system including administration by inhalation. The investment will facilitate a long-term strategic partnership…
Pharmaceutical company Cipla Limited announced the appointment of Ashish Adukia as Global Chief Financial Officer, with effect from August 16, 2022. According to the company’s exchange filing, “we hereby notify that the Board of Directors, at its meeting held today i.e. August 16, 2022, has approved the appointment of Mr. Ashish Adukia as the Global…
Pharmaceutical company Cipla Limited announced the appointment of Dr. Mandar Purushottam Vaidya as an Independent Director of the company, with effect from July 29, 2022. According to the company’s exchange filing, “the Board of the Directors at its meeting held today i.e., on 29th July 2022, has appointed Dr. Mandar Purushottam Vaidya (DIN: 09690327) as…
Cipla Limited (Cipla) announced that Cipla Health Limited (CHL), wholly owned subsidiary and consumer healthcare arm of the Company has signed definitive agreements for acquisition of Endura Mass, a renowned nutritional supplement brand in the category of weight gain from Medinnbelle Herbalcare Private Limited. Endura and all other associated trademarks would be part of the…
Cipla Limited (Cipla) announced that it has agreed to acquire additional stake for INR 25.90 cr. in digital tech company GoApptiv Private Limited (hereinafter referred as “Goapptiv”) and post completion of the deal, Cipla’s total stake in GoApptiv will increase to 22.02% on a fully diluted basis. The investment will be made in equity shares…
Pharma major Cipla Limited announced that it has signed definitive agreements for acquisition of 21.05% stake for an amount of INR 25 crores (approx.) in Achira Labs Private Limited (Achira) engaged in development and commercialization of point of care (PoC) medical test kits in India. This investment will facilitate a Cipla entity’s strategic participation in…
Cipla Limited announced that it has been awarded winner as a “Challenger in Mega Large Business Pharma Sector” by Frost & Sullivan and TERI’s Sustainability 4.0 Awards. The award is a testimony to Cipla’s continuous efforts in the Environment, Social & Governance (ESG) space as a leader in the pharma industry. The company has been…
Cipla Limited, a global pharmaceutical company and Kemwell Biopharma Private Limited, a leading biopharmaceutical Contract Development and Manufacturing Organisation (CDMO), announced execution of a joint venture agreement to develop, manufacture and commercialise biosimilars for global markets. For this purpose, a joint venture company shall be incorporated with an aim to enter the respiratory biosimilars space,…
Cipla Limited announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‘ViraGen’ for COVID-19 in India, in partnership with Ubio Biotechnology Systems Pvt. Ltd. ViraGen is Cipla’s third offering in the Covid-19 testing segment. Cipla already has partnerships for antibody detection kit and antigen test kits. Cipla is staying true to its promise…
Cipla Limited announced it has signed a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company, USA for the manufacture and commercialization of the drug baricitinib for Covid-19 indication. Baricitinib was issued a restricted emergency use approval by the Central Drugs Standard Control Organization (CDSCO), Ministry of Health, India for use in combination with…
Pharma major Cipla announced it has re-appointed Umang Vohra as Managing Director and Global Chief Executive Officer for a period of five years, effective from 1st April, 2021. “In compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that based on the recommendation of Nomination…
Cipla Limited has announced that it’s subsidiary, Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand. As part of this strategic alliance, Cipla Gulf will be responsible for commercialization of patented biosimilars of the biologic medicine brands, Aflibercept (Eylea®️), Ustekimumab…
Pharmaceutical major, Cipla, has appointed Ratna Joshi as Global Head – Talent Management. Joshi joins Cipla from Mahindra & Mahindra, where she was Head – Learning & Development in the Automotive and Farm Sectors of the company. She worked at M&M for more than 10 years. Joshi has 16 years of diverse experience as an…